350 research outputs found
Newly diagnosed Glioblastoma Multiforme (GBM) during COVID-19 pandemic: changes in therapeutic approach to minimize in-hospital SARS-COV-2 contagion in pre-vaccine era
Get PDFEuropean Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Get PDF
Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?
Get PDFCenter for Neuro-Oncology in Turin (Italy):
Get PDFThe Center for Neuro-Oncology of the University Hospital in Turin is hosted by the Division of Neuro-Oncology/Neurology and coordinates the Multidisciplinary Brain Tumor Board (MTB; which includes ..
Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases
Get PDFBevacizumab and temozolomide in secondary gliomatosis from gemistocytic astrocytoma: a case report
Get PDFGliomatosis cerebri is a rare diffuse glioma with a growth pattern consisting of exceptionally extensive infiltration of the CNS with involvement of at least three lobes. It may appear de novo (primary gliomatosis) or result from the spreading of a focal glioma (secondary gliomatosis). Bevacizumab is a monoclonal antibody anti-VEGF active against recurrent high grade gliomas after standard therapy. We report the case of a 41-year-old man with a secondary gliomatosis treated with bevacizumab and temozolomide who responded and the response lasted 17 months. Moreover, we focus on the side effects (hypertension, deep vein thrombosis) induced by bevacizumab and their effective treatments
- …
